Showing results (21-30 of 297) with videos related to

Sort By:
Pageof 30
Clinical Chemistry and Laboratory Medicine|October 4, 2005
Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctionsStefano Zoccolella, Paolo Lamberti, Giovanni Iliceto, et al.
Archives of Neurology|March 14, 2002
Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter studyGiovanni Defazio, Giovanni Abbruzzese, Paolo Girlanda, et al.
Clinical Chemistry and Laboratory Medicine|June 17, 2006
Elevated plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with dyskinesiasStefano Zoccolella, Paolo Lamberti, Giovanni Iliceto, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 26, 2009
Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT studyFrancesco Roselli, Nicola M Pisciotta, Robert Perneczky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 11, 2005
Relationship between eye symptoms and blepharospasm: a multicenter case-control studyDavide Martino, Giovanni Defazio, Giovanni Alessio, et al.
Recent Patents on CNS Drug Discovery|January 29, 2008
Voltage-gated sodium channel blockers as immunomodulatorsFrancesco Roselli, Paolo Livrea, Emilio Jirillo
Movement Disorders : Official Journal of the Movement Disorder Society|April 9, 2009
Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementiaStefano Zoccolella, Claudia dell'Aquila, Giovanni Abruzzese, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 19, 2005
Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-betaMaurizio Giorelli, Paolo Livrea, Maria Trojano
Pageof 30